JCR Pharmaceuticals Co., Ltd.
JCRRF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$455.87M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $455.87 Million |
|---|---|
| Enterprise Value | $44.42 Billion |
| Annual dividend | $0.13 |
| Dividend yield | 3.68% |
| Earnings per Share | $17.58 |
| Beta | 0.56 |
| Outstanding Shares | 122,216,000 |
Return
| Return on Equity | -7.93% |
|---|---|
| Return on Assets | -3.22% |
| Return on Invested Capital | -5.30% |
Valuation & Multiples
| P/E Ratio | -19.55 |
|---|---|
| PEG | 10.48 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 1.14 |
| Enterprise Value to EBIT | -14.79 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 1.21 |
| Debt to Equity | 1.25 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
$0.00
Consensus analyst estimateRevenue Estimate
$80.16 M
Consensus analyst estimateNext Earnings Call
Expected Date
January 28, 2027
EPS Estimate
$-0.09
Consensus analyst estimateRevenue Estimate
$75.53 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About JCR Pharmaceuticals Co., Ltd.
985 employees
CEO: Toru Ashida
JCR Pharmaceuticals Co., Ltd. is a specialized pharmaceutical firm primarily engaged in the creation, development, manufacturing, international trade, and distribution of medicinal products, regenerative therapies, and active pharmaceuti...